Caribou Biosciences, Inc. (CRBU) stock
CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.33−0.01 (-4.29%)
Close on Nov 18, 2026Market cap $34.96MP/E –Yield –
Caribou Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Caribou Biosciences's revenue for the twelve months ending Jun 30, 2026 was $10.04M, up 10.0% year over year. For fiscal 2025 it was $11.16M, up 11.7% from the year before. The highest annual figure on record is $34.48M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.16M | +11.7% |
| FY2024 | Dec 31, 2024 | $9.99M | -71.0% |
| FY2023 | Dec 31, 2023 | $34.48M | +148.9% |
| FY2022 | Dec 31, 2022 | $13.85M | +44.3% |
| FY2021 | Dec 31, 2021 | $9.60M | -22.4% |
| FY2020 | Dec 31, 2020 | $12.36M | +113.6% |
| FY2019 | Dec 31, 2019 | $5.79M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.50M | -43.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.40M | +1.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.94M | +89.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.20M | +8.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.67M | -23.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.35M | -3.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.08M | -41.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.02M | -91.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.46M | -7.7% |
| Q1 FY2024 | Mar 31, 2024 | $2.43M | -30.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.56M | -3.6% |
| Q3 FY2023 | Sep 30, 2023 | $23.66M | +616.4% |
| Q2 FY2023 | Jun 30, 2023 | $3.76M | -10.4% |
| Q1 FY2023 | Mar 31, 2023 | $3.50M | +31.5% |
| Q4 FY2022 | Dec 31, 2022 | $3.69M | +44.3% |
| Q3 FY2022 | Sep 30, 2022 | $3.30M | -16.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.19M | +184.0% |
| Q1 FY2022 | Mar 31, 2022 | $2.66M | +68.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.56M | +160.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.98M | +232.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.48M | -82.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.59M | -6.8% |
| Q4 FY2020 | Dec 31, 2020 | $984.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $1.20M | – |
| Q2 FY2020 | Jun 30, 2020 | $8.48M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.70M | – |
See a number that looks wrong?